Literature DB >> 24368717

Physician nonadherence with a hepatitis C screening program.

William N Southern1, Mari-Lynn Drainoni, Bryce D Smith, Elisa Koppelman, M Diane McKee, Cindy L Christiansen, Allen L Gifford, Cindy M Weinbaum, Alain H Litwin.   

Abstract

BACKGROUND: Testing for patients at risk for hepatitis C virus (HCV) infection is recommended, but it is unclear whether providers adhere to testing guidelines. We aimed to measure adherence to an HCV screening protocol during a multifaceted continuous intervention. SUBJECTS AND METHODS: Prospective cohort design to examine the associations between patient-level, physician-level, and visit-level characteristics and adherence to an HCV screening protocol. Study participants included all patients with a visit to 1 of the 3 study clinics and the physicians who cared for them. Adherence to the HCV screening protocol and patient-level, physician-level, and visit-level predictors of adherence were measured.
RESULTS: A total of 8981 patients and 154 physicians were examined. Overall protocol adherence rate was 36.1%. In multivariate analysis, patient male sex (odds ratio [OR] = 1.18), new patient (OR = 1.23), morning visit (OR = 1.32), and patients' preferred language being non-English (OR = 0.87) were significantly associated with screening adherence. There was a wide variation in overall adherence among physicians (range, 0%-92.4%). Screening adherence continuously declined from 59.1% in week 1 of the study to 13.7% in week 15 (final week). When implementing complex clinical practice guidelines, planners should address physician attitudinal barriers as well as gaps in knowledge to maximize adherence.

Entities:  

Mesh:

Year:  2014        PMID: 24368717      PMCID: PMC5464610          DOI: 10.1097/QMH.0000000000000007

Source DB:  PubMed          Journal:  Qual Manag Health Care        ISSN: 1063-8628            Impact factor:   0.926


  38 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

3.  Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes.

Authors:  James E Calvin; Matthew T Roe; Anita Y Chen; Rajendra H Mehta; Gerard X Brogan; Elizabeth R Delong; Dan J Fintel; W Brian Gibler; E Magnus Ohman; Sidney C Smith; Eric D Peterson
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

4.  Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence.

Authors:  Geva Vashitz; Joachim Meyer; Yisrael Parmet; Yaakov Henkin; Roni Peleg; Harel Gilutz
Journal:  Fam Pract       Date:  2011-05-12       Impact factor: 2.267

5.  Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project.

Authors:  Robert A Gunn; Paula J Murray; Carolyn H Brennan; David B Callahan; Miriam J Alter; Harold S Margolis
Journal:  Sex Transm Dis       Date:  2003-04       Impact factor: 2.830

Review 6.  Measuring adherence to asthma medication regimens.

Authors:  C S Rand; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

Review 7.  Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires.

Authors:  Bruce G Bender; Sarah E Bender
Journal:  Immunol Allergy Clin North Am       Date:  2005-02       Impact factor: 3.479

8.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Prevalence of hepatitis C among psychiatric patients in the public sector.

Authors:  Stephen H Dinwiddie; Louis Shicker; Tom Newman
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

View more
  8 in total

1.  High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.

Authors:  Lesley S Miller; Francois Rollin; Shelly-Ann Fluker; Kristina L Lundberg; Brandi Park; Kristi Quairoli; Nyiramugisha K Niyibizi; Anne C Spaulding
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

2.  Advancing the Public's Health by Scaling Innovations in Clinical Quality.

Authors:  Mary-Beth Malcarney; Katie Horton; Naomi Seiler; Deborah Hastings
Journal:  Public Health Rep       Date:  2017-06-08       Impact factor: 2.792

3.  Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.

Authors:  Bryce D Smith; Anthony K Yartel
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

4.  Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, Florida.

Authors:  Erica B Feldman; Raymond Balise; Eugene Schiff; Nicole Whitehead; Emmanuel Thomas
Journal:  J Community Health       Date:  2017-10

5.  Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States.

Authors:  Charitha Gowda; Vincent Lo Re
Journal:  Curr Hepatol Rep       Date:  2018-03-24

6.  Using mHealth technologies to improve the identification of behavioral health problems in urban primary care settings.

Authors:  Martha Staeheli; Robert H Aseltine; Elizabeth Schilling; Daren Anderson; Bruce Gould
Journal:  SAGE Open Med       Date:  2017-06-08

7.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

8.  Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.

Authors:  Ellen Childs; Sabrina A Assoumou; Katie B Biello; Dea L Biancarelli; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Angela R Bazzi
Journal:  Harm Reduct J       Date:  2019-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.